US HB5228 | 2017-2018 | 115th Congress
Status
Sponsorship: Bipartisan Bill
Status: Engrossed on June 13 2018 - 50% progression, died in committee
Action: 2018-06-13 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on June 13 2018 - 50% progression, died in committee
Action: 2018-06-13 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
SCREEN Act Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act
Title
SCREEN Act Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act
Sponsors
| Rep. Frank Pallone [D-NJ] | Rep. Greg Walden [R-OR] | Rep. Paul Mitchell [R-MI] | Rep. Gerald Connolly [D-VA] |
| Rep. Mike Bost [R-IL] | Rep. Evan Jenkins [R-WV] | Rep. Josh Gottheimer [D-NJ] | Rep. Bill Pascrell [D-NJ] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-06-13 | Senate | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| 2018-06-12 | House | Motion to reconsider laid on the table Agreed to without objection. |
| 2018-06-12 | House | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5049-5051) |
| 2018-06-12 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 5228. |
| 2018-06-12 | House | Considered under suspension of the rules. (consideration: CR H5049-5052) |
| 2018-06-12 | House | Mr. Walden moved to suspend the rules and pass the bill, as amended. |
| 2018-05-17 | House | Ordered to be Reported (Amended) by Voice Vote. |
| 2018-05-17 | House | Committee Consideration and Mark-up Session Held. |
| 2018-04-25 | House | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . |
| 2018-04-25 | House | Subcommittee Consideration and Mark-up Session Held. |
| 2018-03-09 | House | Referred to the Subcommittee on Health. |
| 2018-03-08 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2018-03-08 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2018-03-08 | House | Introduced in House |
Same As/Similar To
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HB5228 (Related) 2018-06-13 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB5803 (Related) 2018-05-15 - Referred to the House Committee on Energy and Commerce.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
HB5228 (Related) 2018-06-13 - Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB5803 (Related) 2018-05-15 - Referred to the House Committee on Energy and Commerce.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
Subjects
Appropriations
Congressional oversight
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Executive agency funding and structure
Food and Drug Administration (FDA)
Government information and archives
Government trust funds
Health
Health programs administration and funding
Health promotion and preventive care
Postal service
Trade restrictions
Congressional oversight
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Executive agency funding and structure
Food and Drug Administration (FDA)
Government information and archives
Government trust funds
Health
Health programs administration and funding
Health promotion and preventive care
Postal service
Trade restrictions
